Wealthy individuals and family offices are investing heavily in longevity startups, with global investment in this sector reaching a record $18.4 billion in 2025, a substantial increase from $4.7 billion in 2024. The first half of 2026 has already seen over $12 billion in investments.
High-profile investors like Jeff Bezos, Sam Altman, and Peter Thiel are leading this trend, indicating a strong belief in the scientific advancements in longevity. Phil Newman, CEO of Longevity.Technology, emphasized that this trend reflects capital following scientific progress rather than mere hype.
The longevity market is expanding beyond traditional biotech to include a variety of health optimization products and services, such as peptides, testosterone, and wellness therapies. This shift is particularly appealing to younger wealthy individuals focused on enhancing their health and fitness.
A Bank of America survey revealed that 94% of wealthy investors are actively working to optimize their health, and 92% consider longevity a critical aspect of their wealth planning. This growing emphasis on healthspan over lifespan suggests a transformative approach to personal finance and investment strategies in the affluent sector